Diagnostic significance of sFRP-4, TFF-3, NF-κB and Romo1 levels in patients with colorectal cancer
Open Access
- 7 February 2024
- journal article
- research article
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 7 (1) , 121-127
Abstract
Objective: Colorectal cancer (CRC) is a significant global health concern with high morbidity and mortality rates. Early detection and accurate diagnostic tools are critical for improving patient outcomes. Our aim in this study was to investigate the diagnostic significance of specific biomarkers - secreted frizzled associated protein-4 (sFRP-4), trefoil factor-3 (TFF-3), nuclear factor-kappa-B (NF-κB), and reactive oxygen species modulator-1 (Romo1) - in patients with CRC. Methods: This study analyzed plasma levels of sFRP-4, TFF-3, NF-κB and Romo1 in a cohort of patients with CRC (n=50) and age- and gender-matched control group (n=40), utilizing ELISA. The diagnostic performance of these biomarkers was assessed through Receiver Operating Characteristic (ROC) analysis. Results: Our research revealed a significant increase in the levels of NF-κB, TFF-3 and Romo1 in patients with a diagnosis of CRC. Furthermore, these parameters were found to maintain elevated levels in patients with tumours larger than 4 cm as opposed to those with smaller tumours. Patients with metastases also had elevated levels of the three parameters compared with patients without metastases. The ROC analysis revealed that NF-κB showed the most promise as a parameter for distinguishing patients from control subjects, whereas TFF-3 displayed the most potential in identifying tumour size and the presence of metastasis. Conclusions: This research contributes valuable insights into the development of non-invasive diagnostic approaches for CRC. The potential of NF-κB, TFF-3 and Romo1 as biomarkers offers a novel avenue for early detection and improved management of CRC, ultimately contributing to better patient outcomes. Further validation and prospective studies are warranted to establish the clinical utility of these biomarkers in CRC diagnosis and screening programs.Keywords
This publication has 38 references indexed in Scilit:
- Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancerBiomedicine & Pharmacotherapy, 2023
- Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational studyArchives of Gynecology and Obstetrics, 2022
- SFRP4 drives invasion in gastric cancer and is an early predictor of recurrenceGastric Cancer, 2020
- Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancerMolecular Biology Reports, 2020
- Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsPathology and Oncology Research, 2020
- The NF-κB signalling pathway in colorectal cancer: associations between dysregulated gene and miRNA expressionJournal of Cancer Research and Clinical Oncology, 2017
- ROMO1 regulates RedOx states and serves as an inducer of NF-κB-driven EMT factors in Fanconi anemiaCancer Letters, 2015
- SFRP4 was overexpressed in colorectal carcinomaJournal of Cancer Research and Clinical Oncology, 2009
- Secreted Frizzled‐related proteins: searching for relationships and patternsBioEssays, 2002
- Transcription Factor NF-κB Signals Antianoikic Function of Trefoil Factor 3 on Intestinal Epithelial CellsBiochemical and Biophysical Research Communications, 2000